Skynner Michael, Chief Technology Officer at Bicycle Therapeutics plc ($BCYC), made eight open market sales of company shares over the last year, totaling $84,280. His most recent sale occurred on January 5, 2026. These transactions rank 9,806th among 11,678 insiders in the database by sale value, well below the average of $8.6 million across 6.37 transactions per insider. He reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 69,303,746 | 9999.99% | 0.14% |
| Jan. 5, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 3266 | $6.46 | 161,966.0000 | 69,303,746 | 1.98% | 0.00% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 3045 | $6.80 | 165,232.0000 | 69,303,746 | 1.81% | 0.00% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | A | Ordinary Shares | 50000 | $0.00 | 168,277.0000 | 69,303,746 | 42.27% | 0.07% |
| Oct. 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 978 | $8.41 | 118,277.0000 | 69,303,746 | 0.82% | 0.00% |
| Oct. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 824 | $8.40 | 119,255.0000 | 69,303,746 | 0.69% | 0.00% |
| July 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 825 | $7.09 | 121,045.0000 | 69,252,009 | 0.68% | 0.00% |
| July 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 966 | $7.44 | 120,079.0000 | 69,252,009 | 0.80% | 0.00% |
| April 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 814 | $8.02 | 122,908.0000 | 69,196,945 | 0.66% | 0.00% |
| April 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 1038 | $7.48 | 121,870.0000 | 69,196,945 | 0.84% | 0.00% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | A | Employee Stock Option (right to buy) | 87000 | $0.00 | 87,000.0000 | 58,207,593 | 9999.99% | 0.15% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | A | Ordinary Shares | 35000 | $0.00 | 127,945.0000 | 58,207,593 | 37.66% | 0.06% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 3287 | $14.09 | 124,658.0000 | 58,207,593 | 2.57% | 0.01% |
| Jan. 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 936 | $14.75 | 123,722.0000 | 58,207,593 | 0.75% | 0.00% |
| Oct. 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 972 | $22.26 | 92,945.0000 | 68,988,858 | 1.03% | 0.00% |
| July 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 967 | $19.64 | 93,917.0000 | 51,992,034 | 1.02% | 0.00% |
| April 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | CHIEF TECHNOLOGY OFFICER | S | Ordinary Shares | 955 | $23.81 | 94,884.0000 | 42,560,091 | 1.00% | 0.00% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | Chief Technology Officer | A | Employee Stock Option (right to buy) | 56000 | $0.00 | 56,000.0000 | 35,592,362 | 9999.99% | 0.16% |
| Jan. 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | Chief Technology Officer | S | Ordinary Shares | 2643 | $17.50 | 95,839.0000 | 35,592,362 | 2.68% | 0.01% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | Chief Technology Officer | A | Ordinary Shares | 28000 | $0.00 | 98,482.0000 | 35,592,362 | 39.73% | 0.08% |
| Oct. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | Chief Technology Officer | S | Ordinary Shares | 442 | $20.00 | 70,482.0000 | 39,576,467 | 0.62% | 0.00% |
| July 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | Chief Technology Officer | S | Ordinary Shares | 451 | $25.10 | 70,924.0000 | 30,191,693 | 0.63% | 0.00% |
| April 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | Chief Technology Officer | S | Ordinary Shares | 447 | $21.11 | 71,375.0000 | 30,001,725 | 0.62% | 0.00% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | Chief Technology Officer | S | Ordinary Shares | 1801 | $29.06 | 71,822.0000 | 29,660,659 | 2.45% | 0.01% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | Chief Technology Officer | A | Employee Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 29,660,659 | 9999.99% | 0.12% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Skynner Michael | Chief Technology Officer | A | Ordinary Shares | 17500 | $0.00 | 73,623.0000 | 29,660,659 | 31.18% | 0.06% |